SCHG vs XLV
Schwab US Large-Cap Growth ETF vs Health Care Select Sector SPDR Fund
- • SCHG has the lower expense ratio at 0.04% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.60%).
Side-by-side metrics
| Metric | SCHG | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.08% |
Dividend yield Trailing 12-month yield. | 0.39% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $59.07B | $40.60B |
YTD return | 5.17% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.21 | 0.51 |
P/E ratio | 32.30 | 29.12 |
Last price | $34.44 | $161.81 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHG top holdings
| NVDA | NVIDIA Corp | 10.02% |
| AAPL | Apple Inc | 8.78% |
| MSFT | Microsoft Corp | 5.81% |
| AMZN | Amazon.com Inc | 4.99% |
| GOOGL | Alphabet Inc Class A | 4.40% |
| AVGO | Broadcom Inc | 3.74% |
| GOOG | Alphabet Inc Class C | 3.52% |
| LLY | Eli Lilly and Co | 3.31% |
| AMD | Advanced Micro Devices Inc | 2.89% |
| TSLA | Tesla Inc | 2.82% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About SCHG
SCHG (Schwab US Large-Cap Growth ETF) is Large-cap US growth at low cost. Managed by Schwab, the fund carries $59.1B in assets under management, an expense ratio of 0.04%, a dividend yield of 0.39%. Its largest holding is NVIDIA Corp (NVDA), which represents 10.0% of the portfolio. Real Estate is the fund's largest sector exposure at 0.6%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.